Clinical Trial: An Open-label, Observational, Long-term Follow-up Study Evaluating the Safety and Efficacy of RGL-193 Putamen Injection in Patients With Primary Parkinson's Disease

U.S., Dec. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07279844) titled 'An Open-label, Observational, Long-term Follow-up Study Evaluating the Safety and Efficacy of RGL-193 Putamen Injection in Patients With Primary Parkinson's Disease' on Dec. 01.

Brief Summary: To evaluate the long-term safety of RGL-193 capsid injection in patients with primary Parkinson's disease over 5 years

Study Start Date: Dec. 15

Study Type: OBSERVATIONAL

Condition: Parkinson's Disease

Intervention: OTHER: Observational

Long-term observational

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Anhui Provincial Hospital

Disclaimer: Curated by HT Syndication....